Legal
Accessibility
Last updated September 2026
We want this site to be usable by everyone who needs it, including people using a keyboard, a screen reader, magnification or reduced-motion settings.
Our commitment
This website is built with the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA as the working target. That is the standard we design and test against — not a claim of certified conformance, and not the result of an independent audit.
What has been done
- Semantic headings, landmarks and lists, with one main region per page and a skip link to it.
- Full keyboard operation, including the navigation menu, the question disclosures and the six-step project brief, with visible focus indicators.
- Form fields with real labels, 16px input text, clear error messages tied to the field they describe, and tap targets of at least 44px.
- Text and interface colours checked against the contrast requirements of the standard.
- Layouts tested for reflow at small screen widths and under zoom, without horizontal scrolling or overlapping content.
- Motion kept minimal and reduced further when your system requests reduced motion.
- Descriptive alternative text on meaningful images; decorative imagery hidden from screen readers.
Known limitations
Testing so far has been carried out by the development team using keyboard navigation, automated checks and manual review at desktop and mobile widths. No independent third-party audit and no formal assistive-technology certification has been completed, so problems may remain — particularly in the more visually composed sections.
Reporting a problem
If any part of this site is difficult or impossible to use, please email projects@exordiumbiotech.com and describe the page and what happened. Tell us what you were using — browser, device and any assistive technology — if you can. We will respond and fix what we can, and we will offer another way to give us the same information in the meantime.
If the project brief is not usable for you, email the same address with the objective in plain terms. Nothing about the form is required to start a conversation.
Questions about this page can be sent to projects@exordiumbiotech.com.
This notice describes current practices for this website in plain English. It is not legal advice, and it is pending final review by counsel.